ACM
XPH icon

Argentus Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Argentus Capital Management’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-638
Closed -$32.5K – 688
2015
Q3 		$30K Buy
+638
New +$38.4K ﹤0.01% 512

Other funds holding XPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

Argentus Capital Management's XPH Position: Q4 2015 in Review

Argentus Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2015, closing a stake of 638 shares — an estimated $32.5K sold.

Argentus Capital Management first reported a position in XPH in Q3 2015 and held it in 1 quarter. The position peaked at $30K in Q3 2015. 76 funds tracked by Wall St. Rank hold XPH as of Q4 2015.

  • Argentus Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
  • Argentus Capital Management sold 638 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2015, an estimated $32.5K.
  • Argentus Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2015 and held it in 1 quarter.
  • Argentus Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $30K in Q3 2015.
  • 76 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2015.

Based on Argentus Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.